Tumor antigen–specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor–modified T cells (original) (raw)

• Verma, I. & Somia, N. Gene therapy—promises, problems and prospects. Nature 389, 239–242 (1997).
  Article CAS Google Scholar
• Vile, R.G., Russell, S.J. & Lemoine, N.R. Cancer gene therapy: hard lessons and new courses. Gene Ther. 7, 2–8 (2000).
  Article CAS Google Scholar
• Russell, S.J. & Cosset, F.-J. Modifying the host range properties of retroviral vectors. J. Gene Med. 1, 300–311 (1999).
  Article CAS Google Scholar
• Grill, J. et al. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin. Cancer Res. 7, 641–650 (2001).
  CAS PubMed Google Scholar
• Krasnykh, V., Belousova, N., Korokhov, N., Mikheeva, G. & Curiel, D.T. Genetic Targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75, 4176–4183 (2001).
  Article CAS Google Scholar
• Wu, P. et al. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol. 74, 8635–8647 (2000).
  Article CAS Google Scholar
• Kirn, D., Martuza, R.L. & Zwiebel, J. Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat. Med. 7, 781–787 (2001).
  Article CAS Google Scholar
• Alemany, R., Balague, C. & Curiel, D.T. Replicative adenoviruses for cancer therapy. Nat. Biotechnol. 18, 723–727 (2000).
  Article CAS Google Scholar
• Takeuchi, Y. et al. Sensitization of cells and retroviruses to human serum by (α1-3) galactosyltransferase. Nature 379, 85–88 (1996).
  Article CAS Google Scholar
• Chirmule, N. et al. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40–CD40 ligand interactions. J. Virol. 74, 3345–3352 (2000).
  Article CAS Google Scholar
• Paillard, F. Circumventing adenovirus immune response to achieve long-term correction of genetic diseases. Hum. Gene Ther. 9, 454–456 (1998).
  CAS PubMed Google Scholar
• Pizzato, M., Marlow, S.A., Blair, E.D. & Takeuchi, Y. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J. Virol. 73, 8599–8611 (1999).
  CAS PubMed PubMed Central Google Scholar
• Alemany, R., Suzuki, K. & Curiel, D.T. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81(Pt 11), 2605–2609 (2000).
  Article CAS Google Scholar
• Griffiths, L. et al. The macrophage—a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7, 255–262 (2000).
  Article CAS Google Scholar
• Carta, L. et al. Engineering of macrophages to produce IFN-γ in response to hypoxia. J. Immunol. 166, 5374–5380 (2001).
  Article CAS Google Scholar
• Pastorino, S., Massazza, S., Cilli, M., Varesio, L. & Bosco, M.C. Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer. Gene Ther. 8, 431–441 (2001).
  Article CAS Google Scholar
• Rosenberg, S.A. Adoptive immunotherapy of cancer: accomplishments and prospects. Cancer Treat. Rep. 68, 233–255 (1984).
  CAS PubMed Google Scholar
• Ioannides, C.G. & Whiteside, T.L. T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin. Immunol. Immunopathol. 66, 91–106 (1993).
  Article CAS Google Scholar
• Melief, C.J. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58, 143–175 (1992).
  Article CAS Google Scholar
• Whiteside, T.L. Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy. Clin. Diag. Lab. Immunol. 7, 327–332 (2000).
  CAS Google Scholar
• Yee, C. et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J. Exp. Med. 192, 1637–1644 (2000).
  Article CAS Google Scholar
• Yee, C., Riddell, S.R. & Greenberg, P.D. In vivo tracking of tumor-specific T cells. Curr. Opin. Immunol. 13, 141–146 (2001).
  Article CAS Google Scholar
• Di Carlo, E. et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97, 339–345 (2001).
  Article CAS Google Scholar
• Rosenberg, S.A. The immunotherapy and gene therapy of cancer. J. Clin. Onc. 10, 180–199 (1992).
  Article CAS Google Scholar
• Gomez-Navarro, J. et al. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Ther. 7, 43–52 (2000).
  Article CAS Google Scholar
• Asahara, T. et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221–228 (1999).
  Article CAS Google Scholar
• Boon, T. & van der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725–729 (1996).
  Article CAS Google Scholar
• Altenschmidt, U., Klundt, E. & Groner, B. Adoptive transfer of _in vitro_-targeted, activated T lymphocytes results in total tumor regression. J. Immunol. 159, 5509–5515 (1997).
  CAS Google Scholar
• Bolhuis, R.L. & Gratama, J.W. Genetic re-targeting of T lymphocyte specificity. Gene Ther. 5, 1153–1155 (1998).
  Article CAS Google Scholar
• Brocker, T., Riedinger, M. & Karjalainen, K. Redirecting the complete T cell receptor/CD3 signaling machinery towards native antigen via modified T cell receptor. Eur. J. Immunol. 26, 1770–1774 (1996).
  Article CAS Google Scholar
• Eshhar, Z., Waks, T., Gross, G. & Schindler, D.G. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. USA 90, 720–724 (1993).
  Article CAS Google Scholar
• Hombach, A. et al. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA. Gene Ther. 6, 300–304 (1999).
  Article CAS Google Scholar
• Weijtens, M.E., Willemsen, R.A., Valerio, D., Stam, K. & Bolhuis, R.L. Single chain Ig/γ gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. J. Immunol. 157, 836–843 (1996).
  CAS Google Scholar
• Alvarez-Vallina, L., Agha-Mohammadi, S., Hawkins, R.E. & Russell, S.J. Pharmacological control of antigen responsiveness in genetically modified T lymphocytes. J. Immunol. 159, 5889–5895 (1997).
  CAS PubMed Google Scholar
• Alvarez-Vallina, L., Yanez, R., Blanco, B., Gil, M. & Russell, S.J. Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors. Cancer Gene Ther. 7, 526–529 (2000).
  Article CAS Google Scholar
• DiDonato, J. et al. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell Biol. 16, 1295–1304 (1996).
  Article CAS Google Scholar
• Sen, J. et al. Expression and induction of nuclear factor-κB-related proteins in thymocytes. J. Immunol. 154, 3213–3221 (1995).
  CAS PubMed Google Scholar
• Trushin, S.A., Pennington, K.N., Algeciras-Schimnich, A. & Paya, C.V. Protein kinase C and calcineurin synergize to activate IκB kinase and NF-κB in T lymphocytes. J. Biol. Chem. 274, 22923–22931 (1999).
  Article CAS Google Scholar
• Hollander, G.A. On the stochastic regulation of interleukin-2 transcription. Semin. Immunol. 11, 357–367 (1999).
  Article CAS Google Scholar
• Jain, J., Loh, C. & Rao, A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7, 333–342 (1995).
  Article CAS Google Scholar
• Cantrell, D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14, 259–274 (1996).
  Article CAS Google Scholar
• Beg, A.A. et al. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6, 1899–1913 (1992).
  Article CAS Google Scholar
• Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997).
  Article CAS Google Scholar
• McElhinny, J.A. et al. Regulation of IκB α and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J. Virol. 69, 1500–1509 (1995).
  CAS PubMed PubMed Central Google Scholar
• Duisit, G., Salvetti, A., Moullier, P. & Cosset, F.L. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum. Gene Ther. 10, 189–200 (1999).
  Article CAS Google Scholar
• Morgenstern, J.P. & Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587–3596 (1990).
  Article CAS Google Scholar
• Diaz, R.M., Eisen, T., Hart, I.R. & Vile, R.G. Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma. J. Virol. 72, 789–795 (1998).
  CAS PubMed PubMed Central Google Scholar
• Emiliusen, L. et al. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component. Gene Ther. 8, 987–998 (2001).
  Article CAS Google Scholar
• Richards, C.A., Austin, E.A. & Huber, B.E. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6, 881–893 (1995).
  Article CAS Google Scholar
• Wagner, M.J., Sharp, J.A. & Summers, W.C. Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 78, 1441–1445 (1981).
  Article CAS Google Scholar
• Vile, R.G., Nelson, J.A., Castleden, S., Chong, H. & Hart, I.R. Systemic gene therapy of murine melanoma using tissue-specific expression of the HSVtk gene involves an immune component. Cancer Res. 54, 6228–6234 (1994).
  CAS PubMed Google Scholar
• Freeman, S.M. et al. The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274–5283 (1993).
  CAS PubMed Google Scholar
• Alvarez-Vallina, L. & Russell, S. Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies. Hum. Gene Ther. 10, 559–563 (1999).
  Article CAS Google Scholar
• Patel, S.D. et al. Impact of chimeric immune receptor extracellular protein domains on T cell function. Gene Ther. 6, 412–419 (1999).
  Article CAS Google Scholar
• Miller, D.G., Adam, M.A. & Miller, A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239–4242 (1990).
  Article CAS Google Scholar
• Culver, K.W. et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550–1552 (1992).
  Article CAS Google Scholar
• Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–266 (1996).
  Article CAS Google Scholar
• Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871–875 (1997).
  Article CAS Google Scholar